These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16010067)

  • 1. Valproate-induced hyperammonemic encephalopathy with normal liver function.
    Rath A; Naryanan TJ; Chowdhary GV; Murthy JM
    Neurol India; 2005 Jun; 53(2):226-8. PubMed ID: 16010067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of valproate-induced hyperammonemic encephalopathy: look beyond the liver.
    Alqahtani S; Federico P; Myers RP
    CMAJ; 2007 Sep; 177(6):568-9. PubMed ID: 17846437
    [No Abstract]   [Full Text] [Related]  

  • 3. Valproate-induced hyperammonemic encephalopathy and normal liver functions: possible synergism with topiramate.
    Deutsch SI; Burket JA; Rosse RB
    Clin Neuropharmacol; 2009; 32(6):350-2. PubMed ID: 19952878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topiramate-valproate-induced hyperammonemic encephalopathy syndrome: case report.
    Cheung E; Wong V; Fung CW
    J Child Neurol; 2005 Feb; 20(2):157-60. PubMed ID: 15794187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproate-induced hyperammonemic encephalopathy: imaging findings on diffusion-weighted MRI.
    Grubben B; De Jonghe P; Cras P; Demey HE; Parizel PM
    Eur Neurol; 2004; 52(3):178-81. PubMed ID: 15528922
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute hyperammonemic coma with chronic valproic acid therapy.
    Cuturic M; Abramson RK
    Ann Pharmacother; 2005 Dec; 39(12):2119-23. PubMed ID: 16288075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproate-induced hyperammonemic encephalopathy: a case report and brief review of the literature.
    Sunkavalli KK; Iqbal FM; Singh B; Koneru J
    Am J Ther; 2013; 20(5):569-71. PubMed ID: 21248614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyperammonemic encephalopathy associated with valproate acid].
    Osuna MT; Burcet J; Ramió L; Ustrell X; Silva Y; Molins A
    Neurologia; 2003; 18(6):347-50. PubMed ID: 12838456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproate-induced hyperammonemic encephalopathy in the presence of topiramate.
    Hamer HM; Knake S; Schomburg U; Rosenow F
    Neurology; 2000 Jan; 54(1):230-2. PubMed ID: 10636156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two cases of valproate-induced hyperammonemic encephalopathy without hepatic failure.
    Panda S; Radhakrishnan K
    J Assoc Physicians India; 2004 Sep; 52():746-8. PubMed ID: 15839456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproate induced non hepatic hyperammonaemic encephalopathy (VNHE)--a study from tertiary care referral university hospital, north India.
    Mehndiratta MM; Mehndiratta P; Phul P; Garg S
    J Pak Med Assoc; 2008 Nov; 58(11):627-31. PubMed ID: 19024136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Valproate-associated hyperammonemic encephalopathy. Report of one case].
    Young P; Finn BC; Alvarez F; Bruetman JE; Trimarchi H
    Rev Med Chil; 2007 Nov; 135(11):1446-9. PubMed ID: 18259656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different clinical manifestations of hyperammonemic encephalopathy.
    Gomceli YB; Kutlu G; Cavdar L; Sanivar F; Inan LE
    Epilepsy Behav; 2007 Jun; 10(4):583-7. PubMed ID: 17412645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproate-induced Hyperammonemic Encephalopathy Presenting as Catatonia.
    Pérez-Esparza R; Oñate-Cadena N; Ramírez-Bermúdez J; Espínola-Nadurille M
    Neurologist; 2018 Mar; 23(2):51-52. PubMed ID: 29494435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproate-induced hyperammonemic encephalopathy in a renal transplanted patient.
    Melexopoulou C; Marinaki S; Darema M; Skalioti C; Efthimiou A; Zavos G; Boletis JN
    Ren Fail; 2014 Jul; 36(6):955-6. PubMed ID: 24665854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproate induced hyperammonemic encephalopathy successfully treated with levocarnitine.
    Rigamonti A; Lauria G; Grimod G; Bianchi G; Salmaggi A
    J Clin Neurosci; 2014 Apr; 21(4):690-1. PubMed ID: 24119342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encephalopathy in an infant with infantile spasms: possible role of valproate toxicity.
    Sivathanu S; Sampath S; Veerasamy M; Sunderkumar S
    BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24810446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Valproate-induced hyperammonemic encephalopathy].
    Granel B; Gavaret M; Le Baut X; Sautereau N; Rodriguez D; Rossi P; Bagnères D; Demoux AL; Francès Y
    Rev Med Interne; 2011 Jun; 32(6):e72-5. PubMed ID: 20633966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproate-induced hyperammonemic encephalopathy treated by hemodialysis.
    Tsai MF; Chen CY
    Ren Fail; 2008; 30(8):822-4. PubMed ID: 18791959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproate-induced hyperammonemic encephalopathy, rapidly improved by i.v. carnitine and glucose/thiamine.
    Bøhmer T; Bøen A; Høymork SC
    Scand J Gastroenterol; 2010 Jun; 45(6):762-3. PubMed ID: 20163200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.